Clinical trial
Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter, Phase III Clinical Trial
NCT07332221 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter, Phase III Clinical Trial
- Lead sponsor
- Henan Cancer Hospital
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- January 20, 2026
- Completion date
- October 1, 2031
- Enrollment
- 435 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
esophageal cancer